Abstract
The plant Butea monosperma (Palas) popularly known as 'dhak' or 'palas' and commonly known as ‘Flame of forest’ belongs to family Fabaceae. This herb is indigenous to India. The plant is traditionally reported to possess astringent, bitter, alterative, aphrodisiac, anthelmintic, antibacterial and anti-asthmatic, anthelmintic, anti-conceptive, anti-convulsive, anti-diabetic, anti-diarrhoeal, anti-estrogenic, anti-fertility, anti-microbial, anti-fungal, anti-bacterial, anti-stress, chemopreventive, hepatoprotective. The present research investigation was envisaged on pharmacognostical standardization, formulation and evaluation of tablets incorporated with methanolic extract of stem bark Butea monosperma for anti cancer activity. Conventional release tablets of methanolic extract of Butea monosperma stem bark (MEBMSB) were formulated using Microcrystalline Cellulose as a filler and PVP-k30 as a binder by direct compression method. Finally from this research investigation it can be concluded that methanolic extract of Butea monosperma stem bark has moderate anti-cancer activity when compare to standards and be suggested as a better substitute for the synthetic anti cancer drugs.
 Keywords: Butea monosperma, anti cancer activity, MTT assay, EAC cells, DAC cells, HepG2 cell lines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.